What amount sold does KoKo Medical, Inc. report in Form D filings?

The latest linked filings report $26.6M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was KoKo Medical, Inc.'s most recent SEC filing?

KoKo Medical, Inc.'s most recent Form D filing was on 2026-02-13.

How many investors does KoKo Medical, Inc. have?

The most recent Form D filing lists 29 investor(s).

KoKo Medical, Inc.

CIK: 0001804895·Other Health Care·Malvern, PA

Reported Sold

$26,575,471

Total Filings

Identified Offerings

Last Filed

Feb 13, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Feb 13, 2026Form D — New notice

Reported sold: $7,999,999 · Target: $7,999,999

Rule 506(b)·29 investors

Dec 15, 2023Form D — New notice

Reported sold: $6,000,009 · Target: $11,999,912

Rule 506(b)·33 investors

Jan 4, 2023Form D — New notice

Reported sold: $8,700,489 · Target: $12,535,417

Rule 506(b)·37 investors

Nov 15, 2021Form D — New notice

Reported sold: $2,499,974 · Target: $5,000,000

Rule 506(b)·28 investors

Mar 11, 2020Form D — New notice

Reported sold: $1,375,000 · Target: $2,500,000

Rule 506(b)·11 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 5 identified offerings

$26,575,471

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Skott Greenhalgh

Executive Officer, Director

Appears on 5 filings

Michael Wallace

Executive Officer, Director

Appears on 4 filings

Jason Keiser

Executive Officer

Appears on 4 filings

Matthew Topliff

Director

Appears on 4 filings

William Dai

Director

Appears on 3 filings

Megan Rosengarten

Director

Appears on 2 filings

Tony Natale

Director

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 13, 2026	New	$7,999,999	$7,999,999	29
Dec 15, 2023	New	$11,999,912	$6,000,009	33
Jan 4, 2023	New	$12,535,417	$8,700,489	37
Nov 15, 2021	New	$5,000,000	$2,499,974	28
Mar 11, 2020	New	$2,500,000	$1,375,000	11

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Septal Solutions, Inc.

Other Health Care

Offering target: $10,000,000

Filed Oct 27, 2026